Biosenic (Biosenic) Beginning Cash Position : $2.00 Mil (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Biosenic Beginning Cash Position?

Biosenic's Beginning Cash Position for the quarter that ended in Jun. 2023 was $2.00 Mil.

Biosenic's quarterly Beginning Cash Position increased from Jun. 2022 ($0.80 Mil) to Dec. 2022 ($2.46 Mil) but then declined from Dec. 2022 ($2.46 Mil) to Jun. 2023 ($2.00 Mil).

Biosenic's annual Beginning Cash Position declined from Dec. 2020 ($10.50 Mil) to Dec. 2021 ($0.74 Mil) but then increased from Dec. 2021 ($0.74 Mil) to Dec. 2022 ($0.80 Mil).

Biosenic Beginning Cash Position Historical Data

The historical data trend for Biosenic's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosenic Beginning Cash Position Chart

Biosenic Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Beginning Cash Position

Get a 7-Day Free Trial

9.57

9.08

10.50

0.74

0.80

Biosenic Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Beginning Cash Position	Get a 7-Day Free Trial															17.65	-9.02	0.80	2.46	2.00

Biosenic Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Biosenic Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Biosenic's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosenic (Biosenic) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (GREY:BNZPF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

BT1:Germany BIOS:Belgium

Address

Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, Gosselies, BEL, 1435

Website

https://www.biosenic.com

Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.

Biosenic (Biosenic) Headlines

From GuruFocus

Q2 2021 Bone Therapeutics SA Earnings Call Transcript

By GuruFocus Research • 03-03-2024